A detailed history of Cpwm, LLC transactions in Fortress Biotech, Inc. stock. As of the latest transaction made, Cpwm, LLC holds 762,267 shares of FBIO stock, worth $1.33 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
762,267
Previous 781,767 2.49%
Holding current value
$1.33 Million
Previous $657,000 0.15%
% of portfolio
0.06%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.79 - $22.0 $15,405 - $429,000
-19,500 Reduced 2.49%
762,267 $656,000
Q2 2022

Aug 12, 2022

BUY
$0.8 - $1.5 $95,600 - $179,250
119,500 Added 18.04%
781,767 $657,000
Q1 2022

May 13, 2022

BUY
$1.24 - $2.75 $182,900 - $405,625
147,500 Added 28.65%
662,267 $901,000
Q3 2021

Nov 12, 2021

BUY
$2.82 - $3.7 $9,870 - $12,950
3,500 Added 0.68%
514,767 $1.66 Million
Q2 2021

Aug 13, 2021

BUY
$3.5 - $5.48 $56,000 - $87,680
16,000 Added 3.23%
511,267 $1.83 Million
Q1 2021

May 14, 2021

SELL
$3.16 - $4.89 $34,760 - $53,790
-11,000 Reduced 2.17%
495,267 $1.75 Million
Q3 2020

Nov 13, 2020

BUY
$2.62 - $4.78 $262,000 - $478,000
100,000 Added 24.61%
506,267 $2.05 Million
Q4 2019

Feb 12, 2020

BUY
$1.25 - $2.57 $22,500 - $46,260
18,000 Added 4.64%
406,267 $1.04 Million
Q3 2019

Nov 13, 2019

BUY
$1.26 - $1.96 $248,556 - $386,643
197,267 Added 103.28%
388,267 $547,000
Q1 2019

May 06, 2019

BUY
$0.94 - $2.47 $18,800 - $49,400
20,000 Added 11.7%
191,000 $340,000
Q3 2018

Nov 13, 2018

SELL
$1.44 - $3.13 $70 - $153
-49 Reduced 0.03%
171,000 $274,000
Q2 2018

Dec 21, 2018

BUY
$2.92 - $5.1 $499,463 - $872,349
171,049 New
171,049 $510,000
Q2 2018

Aug 09, 2018

SELL
$2.92 - $5.1 $499,463 - $872,349
-171,049 Closed
0 $0
Q1 2018

Dec 21, 2018

BUY
$3.42 - $5.35 $584,987 - $915,112
171,049 New
171,049 $778,000

Others Institutions Holding FBIO

About Fortress Biotech, Inc.


  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $189M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Cpwm, LLC Portfolio

Follow Cpwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cpwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cpwm, LLC with notifications on news.